Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ivermectin in Treatment of COVID-19
IRCT20200506047323N6Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Hormozgan University of Medical Sciences. Started Nov 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200506047323N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200506047323N6.